Mode
Text Size
Log in / Sign up

IC-ECG-guided port placement in three breast cancer patients with PLSVC showed no complicationsWhen Your Chest Port Takes an Unexpected Route to Your Heart

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that IC-ECG-guided port placement in PLSVC patients showed no complications, but confirm tip location with imaging.

This study utilized a case series and literature review design to evaluate implantable venous access port placement in a population of three breast cancer patients with persistent left superior vena cava (PLSVC). The primary focus was on catheter positioning and safety during the procedure. No comparator group was included, as the intervention was the specific technique applied to this rare congenital venous anomaly.

During the procedure, intracavitary electrocardiogram (IC-ECG) findings indicated PLSVC when a negative P wave appeared and persisted as the catheter advanced toward the predicted insertion length. In response to this finding, the catheter was withdrawn by approximately 3 cm from the predetermined length. Postoperative X-ray and CT imaging confirmed that the final tip position was at the T6 level.

Regarding safety and tolerability, no functional impairment or catheter-related complications occurred in these three patients. The absence of adverse events suggests that this adjusted approach may be feasible for this specific population. However, the study explicitly notes that optimal technique, catheter positioning, and safety considerations remain uncertain. The small sample size of three cases limits the generalizability of these results.

The practice relevance of this evidence is constrained by its observational nature and limited data. When placing a port from the left side, the presence of a negative P wave upon reaching the predetermined length may indicate PLSVC. Consequently, final confirmation of tip location should always rely on imaging rather than relying solely on IC-ECG findings or predetermined lengths.

An unexpected finding during a routine procedure

You are told you need a port. It is a small device placed under the skin of your upper arm or chest, giving chemo a safer path into your body.

It is routine. Most ports are placed in under an hour.

But in a handful of patients, the map of veins leading to the heart does not follow the textbook. And sometimes that only becomes clear during the procedure itself.

A congenital quirk most people never know about

Roughly 1 in every 200 people has a condition called persistent left superior vena cava, or PLSVC. It means that a vein which normally closes up before birth stayed open.

Most people with PLSVC feel completely fine. Their hearts work normally. They often live their entire lives without knowing.

It only matters in a few situations. One of them is when a medical device — like a port or pacemaker — needs to travel through that vein to reach the heart.

Why breast cancer patients end up here

Breast cancer treatment often requires months of intravenous chemotherapy.

Regular IVs cannot handle that. The veins in your arms wear out fast. A port solves the problem by giving nurses a durable, reliable access point that connects to a large central vein.

For breast cancer patients specifically, the port often goes in the upper arm rather than the chest. That spares the surgical area and keeps the scar out of sight.

The old way versus the newer guidance

Traditionally, surgeons used X-ray during the procedure to track where the catheter was going.

A newer technique uses something called intracavitary electrocardiogram, or IC-ECG. Instead of X-ray images, it reads the electrical signals from the heart as the catheter moves closer.

When the catheter sits near a specific spot in the heart, the P wave (a small blip on the EKG that shows the upper heart chamber firing) grows tall and positive. That tells the surgeon the catheter tip is in the right place.

But in patients with PLSVC, something different happens.

In PLSVC, the catheter travels down a path on the left side of the heart instead of the right.

Because the electrical signal now approaches the heart from a new angle, the P wave on the EKG flips — it becomes negative instead of positive.

Think of it like driving toward a landmark from the opposite direction. The landmark itself is unchanged, but your view of it reverses.

What the team observed

Doctors reported on 3 breast cancer patients who all had PLSVC discovered during upper arm port placement.

In each case, the negative P wave appeared right around the expected insertion depth. It stayed negative as the catheter advanced further. The team confirmed the anomaly on X-ray and CT after the procedure.

Imaging placed the catheter tip at roughly the T6 vertebra level — a safe, stable position.

What they learned about safe placement

Here is where the practical finding sits.

Because the left-side route is slightly longer than the standard right-side path, the team pulled the catheter back about 3 centimeters (a little over an inch) from the predicted depth.

That adjustment kept the tip from sitting too deep inside the heart.

None of the three patients had complications. None had problems during chemotherapy. The ports functioned normally throughout treatment.

Finding this anomaly is not an emergency — it just requires awareness and a small technique change.

Why this finding matters for patients

Here is where things get interesting for anyone facing a port placement.

If you have PLSVC and do not know it, your surgical team may only discover it mid-procedure. A good team recognizes the signs, adjusts smoothly, and confirms placement with imaging.

Most patients never notice any difference in their care. The procedure may take slightly longer. That is usually all.

How this fits into cancer care

Port placement has become safer over the past decade with better imaging and EKG guidance.

Case reports like this one build up the shared knowledge base that helps surgical teams recognize rare situations. Over time, that means fewer surprises and fewer complications for patients.

What this means if you are getting a port

First and most importantly — do not worry. PLSVC is usually harmless, and experienced port teams know how to handle it.

If you have had a previous heart scan, pacemaker, or central line that turned up an unusual vein pattern, mention it to your team before the procedure. It gives them a head start.

Ask whether your hospital uses intracavitary EKG or ultrasound guidance. Both are considered best practice for safer placement.

And if you are told during or after the procedure that you have PLSVC, take the note. It may be useful during any future heart procedure.

The limitations of the evidence

Only 3 patients. That is not enough to change any clinical guideline.

All three were breast cancer patients having upper arm ports. The findings may not apply the same way to chest ports, pacemaker leads, or different patient populations.

And this was a single center's experience. Other teams may see different patterns or use different adjustments.

Larger studies pooling PLSVC cases across hospitals would help confirm the 3-centimeter pullback rule and identify the safest tip position.

As port placement moves toward ultrasound and EKG-only techniques (without routine X-ray), recognizing these rare anomalies through electrical signals becomes even more important.

For patients, the takeaway is reassuring. Modern tools let surgeons catch unusual anatomy in real time and adjust on the fly — turning what was once a complication into a manageable variation.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Persistent left superior vena cava (PLSVC) is a rare congenital venous anomaly. Although implantable venous access port placement in PLSVC has been reported, the optimal technique, catheter positioning, and safety considerations remain uncertain. This study describes our experience in managing three breast cancer patients with PLSVC and proposes a safe and efficient approach for port placement. All three cases of PLSVC were identified among breast cancer patients undergoing implantable venous access port placement guided by intracavitary electrocardiogram (IC-ECG). A negative P wave appeared on IC-ECG, and persisted as it advanced toward the predicted insertion length. These findings were reproducible on repeated catheterizations. To avoid excessive tip depth, the catheter was withdrawn by approximately 3 cm from the predetermined length. Postoperative X-ray and CT confirmed the final tip position at the T6 level. No functional impairment or catheter-related complications occurred during the entire course of treatment. Therefore, when placing a port from the left side, the presence of a negative P wave upon reaching the predetermined length may indicate PLSVC. Persistence of the negative P wave during further advancement, or the emergence of bidirectional P waves, should heighten suspicion for this anomaly. Postoperative X-ray and CT can confirm both the presence of PLSVC and the final tip position. Based on observed left-right predetermined length discrepancies in the normal population, withdrawing the catheter by approximately 3 cm from the predicted insertion length provides a useful reference. However, final confirmation of tip location should always rely on imaging.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.